This mechanism favors the adverse effects resulting from AT1 receptor signaling, such as oxidative insult, inflammation, insulin resistance, adipocyte hypertrophy, visceral adiposity and dyslipidemia, which were evidenced in the present study and contribute greatly to cardiovascular disease. Here, INS is linked to metabolic syndrome.